WCM
ADIL

Wealthcare Capital Management’s Adial Pharmaceuticals ADIL Stock Holding History

Wealthcare Capital Management’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$1K – 88
2021
Q1 		$1K Buy
+1
New +$1.51K ﹤0.01% 640

Other funds holding ADIL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wealthcare Capital Management's ADIL Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Adial Pharmaceuticals (ADIL) in Q2 2021, closing a stake of 1 share — an estimated $1K sold.

Wealthcare Capital Management first reported a position in ADIL in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 18 funds tracked by Wall St. Rank hold ADIL as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Adial Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 1 Adial Pharmaceuticals share in Q2 2021, an estimated $1K.
  • Wealthcare Capital Management first reported a position in Adial Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Wealthcare Capital Management's Adial Pharmaceuticals position peaked at $1K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.